tiprankstipranks
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
US Market

Cyclacel Pharmaceuticals (CYCC) Income Statement

Compare
691 Followers

Cyclacel Pharmaceuticals Income Statement

Last quarter (Q3 2024), Cyclacel Pharmaceuticals's total revenue was $10.00K, a decrease of -37.50% from the same quarter last year. In Q3, Cyclacel Pharmaceuticals's net income was $-1.96K. See Cyclacel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 420.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 420.00K$ -32.00K$ -43.00K$ -20.00K$ -20.00K
Operating Expenses
$ 25.87M$ 27.66M$ 22.94M$ 10.64M$ 9.68M
Depreciation and Amortization
$ 31.00K$ 32.00K$ 43.00K$ 20.00K$ 20.00K
EBITDA
$ -25.42M$ -27.62M$ -22.69M$ -10.62M$ -9.66M
Operating Income
$ -25.45M$ -27.66M$ -22.94M$ -10.64M$ -9.68M
Other Income/Expenses
$ -98.00K$ 1.74M$ 204.00K$ 955.00K$ 556.00K
Pretax Income
$ -25.55M$ -25.91M$ -22.73M$ -9.68M$ -9.13M
Net Income
$ -22.55M$ -21.20M$ -18.89M$ -8.45M$ -7.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -26.75$ -32.23$ -31.74$ -34.86$ -143.88
Diluted EPS
$ -26.75$ -32.23$ -31.74$ -34.86$ -143.88
Weighted Average Shares Outstanding
850.82K 657.62K 595.08K 242.22K 54.41K
Weighted Average Shares Outstanding (Diluted)
850.82K 657.62K 595.08K 242.22K 54.41K
Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis